Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Text Size

Compliance With Once Daily Glaucoma Medication

This study has been completed.
Sponsor:
Collaborators:
Johns Hopkins University
University of Pennsylvania
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT00333463
First received: June 1, 2006
Last updated: November 17, 2016
Last verified: March 2010
History of Changes
  Purpose
A study to examine patient compliance with once daily glaucoma medication

Condition Intervention
Compliance
 Behavioral: Intervention

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Compliance With Once Daily Glaucoma Medication

Resource links provided by NLM:

MedlinePlus related topics: Glaucoma
U.S. FDA Resources

Further study details as provided by Alcon Research:
Estimated Enrollment: 700
Study Start Date: June 2006
Study Completion Date: September 2007
Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Intervention group
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
 Behavioral: Intervention
The intervention group watched an educational video, reviewed current barriers to drop-taking and possible solutions with a study coordinator, received regular phone call reminders, and had audible and visible reminders activated on their DA devices.
Non-Intervention Group
The control group was told to take drops as prescribed and received no additional intervention.

  Eligibility
Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Primary open angle glaucoma or ocular hypertension patients
Criteria

Inclusion Criteria:

  • Primary open angle glaucoma or ocular hypertension patients

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00333463

Locations
United States, Texas
Ft. Worth
Ft. Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Johns Hopkins University
University of Pennsylvania
Investigators
Study Director: David Friedman, MD Study Director
  More Information

Publications:

Responsible Party: Alcon Research
ClinicalTrials.gov Identifier: NCT00333463     History of Changes
Other Study ID Numbers: CMS-06-03
Study First Received: June 1, 2006
Last Updated: November 17, 2016

Additional relevant MeSH terms:
Glaucoma
Ocular Hypertension
Eye Diseases

ClinicalTrials.gov processed this record on May 25, 2017